Publications

Members only publications are marked with a lock icon:
Filter By

Large Language Models in Post-Acute and Long-Term Care: Bridging Promise and Practice

JAMDA
July 21, 2026
Post-acute and long-term care (PA/LTC) operates under sustained pressure from workforce shortages, multimorbidity, and a documentation burden implicated in clinician burnout.1 In 2026, the frontier large language model (LLM) landscape, led by Claude...

Reply to Comment on “Concordance Between the Minimum Data Set Kidney Impairment I1500 Item and eGFR Records in Nursing Homes”

JAMDA
July 21, 2026
We thank Sati et al for their thoughtful letter regarding our study1 of concordance between the Minimum Data Set (MDS), version 3.0 I1500 item and estimated glomerular filtration rate (eGFR) laboratory values for identifying kidney impairment among...

Comment on “Concordance Between the Minimum Data Set Kidney Impairment I1500 Item and eGFR Records in Nursing Homes”

JAMDA
July 21, 2026
We read with great interest the study by Radjabova et al,1 which evaluates concordance between the Minimum Data Set (MDS) I1500 item and estimated glomerular filtration rate (eGFR) for identifying kidney impairment in nursing home residents. The...

When Safety Policy Becomes the Hazard: Mobility Restriction and Unexamined Harm in Nursing Home Falls Prevention

JAMDA
July 20, 2026
Falls prevention occupies a dominant position in nursing home quality oversight. What has received far less scrutiny is whether the organizational response to this pressure may itself generate harm through systematic mobility restriction. We write...

Does Lower-Limb Segmentation of DXA Matter in Sarcopenia?

JAMDA
July 3, 2026
Whole-body dual-energy X-ray absorptiometry (DXA) is widely used to assess muscle mass in older adults and serves as a reference method for sarcopenia diagnosis.1 Appendicular skeletal muscle mass, normalized to height squared, plays a central role...

The Illusion of Stability: Deglycemized Diabetic Ketoacidosis in Ambulatory Care With Long-Term SGLT2 Inhibitor Use

JAMDA
July 3, 2026
Sodium-glucose cotransporter 2 (SGLT2) inhibitors have become a cornerstone of contemporary type 2 diabetes management because of their established glycemic, cardiovascular, and renal benefits. However, growing evidence has demonstrated an...

Dermatoporosis: Standardizing Mandarin Terminology and Primary Care Screening

JAMDA
July 3, 2026
Dermatoporosis—a chronic skin fragility syndrome in older adults characterized by skin atrophy, pseudoscar formation, and dissecting hematomas—remains substantially underrecognized in primary care and geriatric practice. First systematically...

Reply to “Beyond Association: Proposing a Clinically Actionable NLR-Sarcopenia Risk Stratification Tool for Post-Acute Care Settings”

JAMDA
July 3, 2026
We are grateful to the authors of the correspondence for their thoughtful engagement with our systematic review and meta-analysis examining the relationship between the neutrophil-to-lymphocyte ratio (NLR) and sarcopenia.1 Their comments recognize...

Beyond Association: Proposing a Clinically Actionable NLR-Sarcopenia Risk Stratification Tool for Post-Acute Care Settings

JAMDA
July 2, 2026
The systematic review and meta-analysis by Wang et al1 provides valuable pooled evidence linking elevated neutrophil-to-lymphocyte ratio (NLR) with sarcopenia. This work underscores NLR's potential as an accessible biomarker. However, a critical...

PALTmed Events and Product

JAMDA
July 1, 2026